News
ATRC
54.42
+2.76%
1.46
Biotech Stocks At 52-Week Highs - PHVS +7%, ROIV +6% On Trial Readouts, BLSM +4%, ATRC, FTH
NASDAQ · 2d ago
Weekly Report: what happened at ATRC last week (0831-0904)?
Weekly Report · 4d ago
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index
Seeking Alpha · 5d ago
S&P 600 adding ten companies at open on 9/21
TipRanks · 6d ago
Biotech Stocks At 52-Week Highs - ATTO, HALO, IKT, TVTX, ATRC
NASDAQ · 09/04 09:15
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Benzinga · 09/02 14:26
Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 09/02 12:27
AtriCure Is Maintained at Buy by Needham
Dow Jones · 09/02 10:11
AtriCure Price Target Raised to $64.00/Share From $45.00 by Needham
Dow Jones · 09/02 10:11
Michael Matson Reiterates Buy on AtriCure, Lifting 12-Month Price Target From $45 to $64 on BoxX-NoAF Trial Upside
TipRanks · 09/02 10:05
Needham Maintains Buy on AtriCure, Raises Price Target to $64
Benzinga · 09/02 10:02
Weekly Report: what happened at ATRC last week (0824-0828)?
Weekly Report · 08/31 09:51
Biotech Stocks At 52-Week Highs - RNXT +12%, BLSM, RVTY, ATRC, BFRI
NASDAQ · 08/31 09:01
AtriCure Is Maintained at Overweight by Piper Sandler
Dow Jones · 08/27 16:53
Piper Sandler Maintains Overweight on AtriCure, Raises Price Target to $60
Benzinga · 08/27 16:43
AtriCure price target raised to $60 from $50 at Piper Sandler
TipRanks · 08/27 10:50
Top Atricure Insider Makes Bold Move With Major Stock Sale
TipRanks · 08/27 02:05
Analog Devices To Rally Around 81%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga · 08/24 13:30
AtriCure price target raised to $55 from $45 at BTIG
TipRanks · 08/24 11:10
AtriCure Is Maintained at Buy by BTIG
Dow Jones · 08/24 10:42
More
Webull provides a variety of real-time ATRC stock news. You can receive the latest news about Atricure through multiple platforms. This information may help you make smarter investment decisions.
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.